Amgen Inc.
CH ˙ SWX ˙ NL0000888691
SecurityCH:AMGN / Amgen Inc.
InstitutionSarasin & Partners LLP
Latest Disclosed Ownership666,450 shares
Latest Disclosed Value $ 234,490,454
Sarasin & Partners LLP reports 1.67% increase in ownership of AMGN / Amgen Inc.

On April 13, 2026 - Sarasin & Partners LLP filed a 13F-HR form disclosing ownership of 666,450 shares of Amgen Inc. (CH:AMGN) valued at $234,490,454 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 8, 2026 disclosing 655,511 shares of Amgen Inc.. This represents a change in shares of 1.67% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-13 2026-03-31 13F AMGEN COM 031162100 666,450 10,939 1.67 234,490 9.29 2.8606
2026-01-08 2025-12-31 13F AMGEN COM 031162100 655,511 -4,482 -0.68 214,555 18.66 2.2276
2025-10-10 2025-09-30 13F AMGEN COM 031162100 659,993 47,873 7.82 180,818 5.80 1.7744
2025-07-09 2025-06-30 13F AMGEN COM 031162100 612,120 54,580 9.79 170,910 -1.61 1.7012
2025-04-15 2025-03-31 13F/A-1 AMGEN COM 031162100 557,540 25,241 4.74 173,702 25.20 1.8837
2025-04-09 2025-03-31 13F AMGEN COM 031162100 818,400 286,101 263,697 2.5417
2025-01-16 2024-12-31 13F AMGEN COM 031162100 532,299 -286,101 -34.96 138,738 -47.39 1.5306
2024-10-09 2024-09-30 13F AMGEN COM 031162100 818,400 -310,136 -27.48 263,697 -25.22 2.4879
2024-07-19 2024-06-30 13F AMGEN COM 031162100 1,128,536 -12,857 -1.13 352,611 8.66 3.1235
2024-04-12 2024-03-31 13F AMGEN COM 031162100 1,141,393 -6,300 -0.55 324,521 -1.83 3.1953
2024-01-10 2023-12-31 13F AMGEN COM 031162100 1,147,693 -36,118 -3.05 330,559 3.90 3.6341
2023-10-05 2023-09-30 13F AMGEN COM 031162100 1,183,811 -59,287 -4.77 318,161 15.28 3.9738
2023-07-11 2023-06-30 13F AMGEN COM 031162100 1,243,098 134,366 12.12 275,993 2.97 3.2007
2023-05-08 2023-03-31 13F/A-1 AMGEN COM 031162100 1,108,732 140,759 14.54 268,036 5.43 3.3807
2023-04-27 2023-03-31 13F AMGEN COM 031162100 1,373,413 405,440 312,163 2.9327
2023-01-30 2022-12-31 13F AMGEN COM 031162100 967,973 -24,789 -2.50 254,228 13.61 3.3296
2022-10-18 2022-09-30 13F AMGEN COM 031162100 992,762 -326,209 -24.73 223,769 -30.27 3.0996
2022-07-13 2022-06-30 13F AMGEN COM 031162100 1,318,971 -44,636 -3.27 320,906 -2.68 4.0463
2022-04-11 2022-03-31 13F AMGEN COM 031162100 1,363,607 -5,828 -0.43 329,747 7.03 3.3157
2022-01-19 2021-12-31 13F AMGEN COM 031162100 1,369,435 165,636 13.76 308,082 20.35 2.8066
2021-10-22 2021-09-30 13F AMGEN COM 031162100 1,203,799 40,507 3.48 255,988 -9.72 2.5833
2021-07-13 2021-06-30 13F AMGEN COM 031162100 1,163,292 64,592 5.88 283,552 3.73 2.9601
2021-04-29 2021-03-31 13F AMGEN COM 031162100 1,098,700 43,409 4.11 273,368 12.67 3.2233
2021-01-19 2020-12-31 13F AMGEN COM 031162100 1,055,291 99,942 10.46 242,633 -0.07 3.2115
2020-11-09 2020-09-30 13F AMGEN COM 031162100 955,349 -10,816 -1.12 242,812 6.55 3.5115
2020-07-17 2020-06-30 13F AMGEN COM 031162100 966,165 -42,703 -4.23 227,880 11.42 3.6449
2020-04-30 2020-03-31 13F AMGEN COM 031162100 1,008,868 -67,122 -6.24 204,528 -21.15 4.0197
2020-02-12 2019-12-31 13F AMGEN COM 031162100 1,075,990 4,667 0.44 259,389 25.12 3.9640
2019-11-08 2019-09-30 13F AMGEN COM 031162100 1,071,323 106,302 11.02 207,312 16.58 3.4303
2019-07-18 2019-06-30 13F AMGEN COM 031162100 965,021 44,977 4.89 177,834 1.74 3.1078
2019-05-13 2019-03-31 13F AMGEN COM 031162100 920,044 57,152 6.62 174,790 4.05 3.3650
2019-02-12 2018-12-31 13F AMGEN COM 031162100 862,892 6,960 0.81 167,979 -5.32 3.6543
2018-11-09 2018-09-30 13F AMGEN COM 031162100 855,932 -120,067 -12.30 177,426 -1.52 3.3435
2018-08-07 2018-06-30 13F AMGEN COM 031162100 975,999 7,660 0.79 180,160 9.13 3.5415
2018-05-01 2018-03-31 13F AMGEN COM 031162100 968,339 49,426 5.38 165,082 3.31 3.2336
2018-02-06 2017-12-31 13F AMGEN COM 031162100 918,913 -6,104 -0.66 159,799 -7.35 3.1049
2017-11-13 2017-09-30 13F AMGEN COM 031162100 925,017 -53,018 -5.42 172,469 2.39 3.4767
2017-08-03 2017-06-30 13F AMGEN COM 031162100 978,035 -20,716 -2.07 168,447 2.80 3.2951
2017-05-15 2017-03-31 13F AMGEN COM 031162100 998,751 -373,925 -27.24 163,865 -18.35 3.1875
2017-02-10 2016-12-31 13F AMGEN COM 031162100 1,372,676 32,811 2.45 200,699 -10.20 3.3937
2016-10-14 2016-09-30 13F AMGEN COM 031162100 1,339,865 18,141 1.37 223,503 11.14 3.5045
2016-07-13 2016-06-30 13F AMGEN COM 031162100 1,321,724 -178,880 -11.92 201,100 -10.62 3.3382
2016-04-27 2016-03-31 13F AMGEN COM 031162100 1,500,604 -10,562 -0.70 224,986 -8.28 3.6710
2016-01-19 2015-12-31 13F AMGEN COM 031162100 1,511,166 -35,209 -2.28 245,308 14.69 4.0773
2015-11-06 2015-09-30 13F AMGEN COM 031162100 1,546,375 239,652 18.34 213,895 6.62 3.8480
2015-08-06 2015-06-30 13F/A-1 AMGEN COM 031162100 1,306,723 -164,826 200,608 3.2653
2015-10-21 2015-06-30 13F/A-2 AMGEN COM 031162100 1,306,723 -164,826 -11.20 200,608 -14.72 3.2909
2015-07-27 2015-06-30 13F AMGEN COM 031162100 1,306,723 200,608
2015-04-13 2015-03-31 13F AMGEN COM 031162100 1,471,549 1,471,549 0.00 235,227 3.5979
2015-01-26 2014-12-31 13F AMGEN COM 031162100 0 -2,400,346 -100.00 0 -100.00
2014-10-23 2014-09-30 13F AMGEN COM 031162100 2,400,346 -45,930 -1.88 337,153 16.43 4.6377
2014-07-14 2014-06-30 13F AMGEN COM 031162100 2,446,276 105,652 4.51 289,566 0.30 4.0523
2014-04-09 2014-03-31 13F AMGEN COM 031162100 2,340,624 100,056 4.47 288,693 12.95 4.1170
2014-02-13 2013-12-31 13F AMGEN COM 031162100 2,240,568 455,205 25.50 255,604 27.91 3.5774
2013-10-09 2013-09-30 13F AMGEN COM 031162100 1,785,363 533,755 42.65 199,827 61.82 3.0482
2013-08-07 2013-06-30 13F AMGEN COM 031162100 1,251,608 1,251,608 123,484 1.7590
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.